What is TG Therapeutics's treasury stock?

TG Therapeutics (TGTX) reported treasury stock of $200.23M in Q1 2026.

How has TG Therapeutics's treasury stock changed year-over-year?

TG Therapeutics's treasury stock increased by 1224.5% year-over-year, from $15.12M to $200.23M.

What is the long-term trend for TG Therapeutics's treasury stock?

Over 5 years (2020 to 2025), TG Therapeutics's treasury stock has grown at a 236.0% compound annual growth rate (CAGR), from $234K to $100.23M.

What does treasury stock mean?

Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

TG Therapeutics TGTX Treasury Stock

Treasury Stock at other companies

BiogenBIIB

$2.98B0.0%

BridgeBio PharmaBBIO

$405.78M+25.5%

Arrowhead ResearchARWR

$53.19M—

Bristol-Myers SquibbBMY

$43.52B-0.2%

Johnson & JohnsonJNJ

$76.26B+0.5%

Royalty PharmaRPRX

$2.71M+2.1%

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's treasury stock?: TG Therapeutics (TGTX) reported treasury stock of $200.23M in Q1 2026.
How has TG Therapeutics's treasury stock changed year-over-year?: TG Therapeutics's treasury stock increased by 1224.5% year-over-year, from $15.12M to $200.23M.
What is the long-term trend for TG Therapeutics's treasury stock?: Over 5 years (2020 to 2025), TG Therapeutics's treasury stock has grown at a 236.0% compound annual growth rate (CAGR), from $234K to $100.23M.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.